Side-by-side comparison of AI visibility scores, market position, and capabilities
Digital health platform with 50M+ patients engaged and 4,500+ hospital deployments; holds FDA 510k clearance for RPM; acquired Aluna (respiratory monitoring) in May 2025 and launched Pfizer hemophilia cloud platform in Jan 2025.
Huma (formerly Medopad) is a London-based digital health company that operates a cloud-based remote patient monitoring (RPM) and decentralized clinical trial platform used by hospitals, health systems, pharmaceutical companies, and medical device manufacturers. Founded in 2011, Huma has grown to serve more than 4,500 hospitals and clinics worldwide, engaging over 50 million patients through its digital health platform. The company's FDA Class II 510k-cleared RPM solution combines a patient-facing mobile app with a clinician portal that enables real-time monitoring of vital signs, symptoms, and treatment adherence, reducing unnecessary hospital admissions and enabling earlier clinical intervention.
Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.